Literature DB >> 23838575

Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.

Atsushi Tanemura1, Naoki Oiso, Mayuko Nakano, Saori Itoi, Akira Kawada, Ichiro Katayama.   

Abstract

BACKGROUND: The precise pathogenesis of alopecia areata remains unknown, although this disease seems to be triggered by helper T cell infiltration in hair follicles. Recent studies of psoriasis and vitiligo have demonstrated the involvement of Th17 cells. Psoriasis and vitiligo occasionally develop concomitantly or inversely in patients with alopecia areata.
OBJECTIVE: The aim of this study was to determine whether Th17 cells are present in the affected lesions of alopecia areata.
METHODS: We performed immunofluorescent staining of representative immunocompetent cells that had infiltrated into the skin of the scalp in 4 individuals with alopecia areata (single patchy alopecia areata, multiple patchy alopecia areata, alopecia totalis and alopecia universalis).
RESULTS: We found the infiltration of CD4(+)IL-17A(+) Th17 cells in the dermis, particularly around hair follicles, in all 4 cases.
CONCLUSIONS: These findings suggest the possibility that alopecia areata is induced by a Th17 cell-associated autoimmune mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23838575     DOI: 10.1159/000350933

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  18 in total

Review 1.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

Review 2.  Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.

Authors:  Xiran Lin; Xianmin Meng; Zhiqi Song
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

Review 5.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

Review 6.  Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases.

Authors:  Agnieszka Wasilewska; Marta Winiarska; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Postepy Dermatol Alergol       Date:  2016-08-16       Impact factor: 1.837

7.  The Contributory Roles of Th17 Lymphocyte and Cytotoxic T Lymphocyte at the Hair Bulge Region as Well as the Hair Bulb Area in the Chronic Alopecia Areata Patients.

Authors:  Jin-Woo Hong; Chae-Young Lee; Seung-Min Ha; Seung-Hwan Choi; Tae-Hoon Kim; Ki-Hoon Song; Ki-Ho Kim
Journal:  Ann Dermatol       Date:  2017-03-24       Impact factor: 1.444

Review 8.  Pathomechanisms of immune-mediated alopecia.

Authors:  Alessandra Anzai; Eddy Hsi Chun Wang; Eunice Y Lee; Valeria Aoki; Angela M Christiano
Journal:  Int Immunol       Date:  2019-07-13       Impact factor: 5.071

Review 9.  Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options.

Authors:  Evan Darwin; Penelope A Hirt; Raymond Fertig; Brett Doliner; Gina Delcanto; Joaquin J Jimenez
Journal:  Int J Trichology       Date:  2018 Mar-Apr

Review 10.  IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art.

Authors:  Nicoletta Bernardini; Nevena Skroza; Ersilia Tolino; Alessandra Mambrin; Alessia Anzalone; Veronica Balduzzi; Daniela Colapietra; Anna Marchesiello; Simone Michelini; Ilaria Proietti; Concetta Potenza
Journal:  Int J Dermatol       Date:  2019-10-30       Impact factor: 2.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.